X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Torrent Pharma Fact Sheet, Torrent Pharma Financial Results - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Torrent Pharma Fact Sheet   (TORR)

Here is the latest financial fact sheet of Torrent Pharma. For more details, see the Torrent Pharma quarterly results and Torrent Pharma share price and chart. For a sector overview, read our pharmaceuticals sector report.

TORRENT PHARMA Price History

Price Rs 1,423.6
Mkt Cap Rs m 240,959
Vol '000 1.2
P/E X 29.1
P/CF X 19.4
EPS (TTM) Rs 48.9
% ch % 1.6
No. of shares m 169.26
% ch week % 1.8
% ch 1-mth % 5.0
% ch 12-mth % 7.1
52 week H/L Rs 1,572.1/1,143.5
(As on Jan 18, 2018 09:43:00 AM)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

TORRENT PHARMA Financials

No. of Mths
Year Ending
12
Mar-13
*
12
Mar-14
*
12
Mar-15
*
12
Mar-16
*
12
Mar-17
*
5-Yr Chart
Click to enlarge
TORRENT PHARMA EQUITY SHARE DATA
High Rs7675781,2321,7201,768 
Low Rs5973345231,1341,186 
Sales per share (Unadj.) Rs379.5247.3275.0394.5346.1 
Earnings per share (Unadj.) Rs51.139.244.4102.455.2 
Diluted earnings per shareRs25.639.244.4102.455.2 
Cash flow per share (Unadj.) Rs60.944.455.6116.573.3 
Dividends per share (Unadj.) Rs23.0010.0011.2540.0014.00 
Adj. dividends per shareRs11.5010.0011.2539.9914.00 
Dividend yield (eoy) %3.42.21.32.80.9 
Book value per share (Unadj.) Rs168.1112.4156.2206.5257.1 
Adj. book value per shareRs84.0112.4156.1206.4257.0 
Shares outstanding (eoy) m84.61169.22169.22169.22169.22 
Bonus/Rights/Conversions  -B1:1--- 
Price / Sales ratio x1.81.83.23.64.3 
Avg P/E ratio x13.311.619.813.926.8 
P/CF ratio (eoy) x11.210.315.812.320.1 
Price / Book Value ratio x4.14.15.66.95.7 
Dividend payout %45.025.525.439.125.4 
Avg Mkt Cap Rs m57,70477,190148,465241,435249,887 
No. of employees `0009.69.511.010.911.8 
Total wages/salary Rs m6,2337,4118,4188,4249,934 
Avg. sales/employee Rs Th3,354.04,386.54,212.46,129.64,971.5 
Avg. wages/employee Rs Th651.0776.8762.0773.4843.2 
Avg. net profit/employee Rs Th452.0695.9679.81,591.3792.4 
TORRENT PHARMA INCOME DATA
Net Sales Rs m32,11141,84746,53566,76458,569 
Other income Rs m4343812,8562,2562,233 
Total revenues Rs m32,54542,22949,39069,02060,802 
Gross profit Rs m6,9229,51510,20227,33013,773 
Depreciation Rs m8278701,9072,3763,069 
Interest Rs m3385861,7521,8402,056 
Profit before tax Rs m6,1918,4409,39825,37110,881 
Minority Interest Rs m-220000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m-37500-1,9360 
Tax Rs m1,4671,8011,8886,1021,545 
Profit after tax Rs m4,3286,6397,50917,3339,336 
Gross profit margin %21.622.721.940.923.5 
Effective tax rate %23.721.320.124.114.2 
Net profit margin %13.515.916.126.015.9 
TORRENT PHARMA BALANCE SHEET DATA
Current assets Rs m25,60934,04540,98346,88253,841 
Current liabilities Rs m17,10721,74627,04632,85531,612 
Net working cap to sales %26.529.430.021.038.0 
Current ratio x1.51.61.51.41.7 
Inventory Days Days10588847497 
Debtors Days Days78961257984 
Net fixed assets Rs m11,05114,09534,72039,00742,079 
Share capital Rs m423846846846846 
"Free" reserves Rs m13,63417,27225,58334,09542,655 
Net worth Rs m14,21919,02426,43034,94143,501 
Long term debt Rs m4,5457,44521,72918,50122,408 
Total assets Rs m37,83950,69879,64190,579101,250 
Interest coverage x19.315.46.414.86.3 
Debt to equity ratio x0.30.40.80.50.5 
Sales to assets ratio x0.80.80.60.70.6 
Return on assets %12.314.311.621.211.3 
Return on equity %30.434.928.449.621.5 
Return on capital %32.734.123.247.319.6 
Exports to sales %37.737.430.443.30 
Imports to sales %7.68.26.06.90 
Exports (fob) Rs m12,11415,66514,13628,9340 
Imports (cif) Rs m2,4333,4162,8014,5840 
Fx inflow Rs m13,22816,86214,26529,18520,066 
Fx outflow Rs m4,7345,1965,1846,0215,304 
Net fx Rs m8,49411,6669,08123,16514,762 
TORRENT PHARMA CASH FLOW
From Operations Rs m 1,535 5,994 8,102 27,421 10,127 
From Investments Rs m -2,417 -3,558 -21,623 -8,379 -7,869 
From Financial Activity Rs m 197 864 12,123 -14,352 -1,918 
Net Cashflow Rs m -685 3,300 -1,399 4,375 212 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 71.5%
Foreign collaborators 0.0%
Indian inst/Mut Fund 7.0%
FIIs 12.6%
ADR/GDR 0.0%
Free float 8.8%
Shareholders 26,511
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF Torrent House, Off Ashram Road, Ahmedabad - 380 009
E-MAIL maheshagrawal@torrentpharma.com WEB www.torrentpharma.com
TELEPHONE (079) 2658 5090 FAX (079) 2658 2100
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT Karvy Computershare, 17-24, Vithalrao Nagar, Madhapur, Hyderabad-81
AUDITOR Deloitte Haskins & Sells
CHM: Sudhir Mehta COMP SEC: Mahesh Agarwal YEAR OF INC: 1973 BSE CODE: 500420 FV (Rs): 5 DIV YIELD (%): 1.0

More Pharmaceuticals Company Fact Sheets:   WOCKHARDT LTD.  SUVEN LIFE  NOVARTIS  ALEMBIC PHARMA  SUN PHARMA  

Compare TORRENT PHARMA With:   WOCKHARDT LTD.  SUVEN LIFE  NOVARTIS  ALEMBIC PHARMA  SUN PHARMA  

Compare TORRENT PHARMA With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex & Nifty Open at Record Highs; Banking & PSU Stocks Rally(09:30 am)

Asian stock markets are higher today as Japanese and Hong Kong shares show gains. The Nikkei 225 is up 0.46% while the Hang Seng is up 0.28%. The Shanghai Composite is trading up by 0.43%.

Views on news

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

Lupin: US Markets Drags down Revenues and Net Profits (Quarterly Results Update - Detailed)

Nov 2, 2017

Domestic markets registers robust growth in the quarter

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

The ONLY Thing You Need to Know About Bitcoin(The 5 Minute Wrapup)

Jan 6, 2018

You either want it or you want to get as far away from it as possible - but Bitcoin is just the noise masking the REAL opportunity. Read about it here...

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK TORRENT PHARMA

  • Track your investment in TORRENT PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TORRENT PHARMA

TORRENT PHARMA - UNICHEM LAB COMPARISON

COMPARE TORRENT PHARMA WITH

MARKET STATS